These findings provide a novel additional mechanistic avenue for the increase of PRLR in cancer to maximize the actions of endogenous/exogenous PRL that upon resistance to hormonal therapy could promote progression and metastasis in breast cancer. This evidence concerns the gene PRLR and breast carcinoma.